In fiscal 2010,  net sales were adversely affected by foreign exchange rates, compared to the previous fiscal year. However, performance was strong in the U.S., led by the Positioning Business, while the Finetech Business spearheaded a solid performance in Japan and China. As a result, group consolidated net sales came to ¥102.47 billion, up 8.0% year-on-year.

The strong yen and higher expenses stemming from measures to bolster the Group’s development capabilities and sales network had a negative impact on income. Thanks to the increase in net sales, however, operating income came to ¥1.799 billion (an increase of 28.1% year-on-year).

The Positioning Business was affected by the strong yen, but growth in the U.S. market resulted in net sales of ¥51.559 billion, an increase of 4.5% year-on-year. Operating income totaled ¥130 million, an increase of ¥123 million year-on-year, as profitability improved in line with rising net sales.

Net sales in the Eye Care Business came to ¥30.946 billion, a decrease of 1.9% year-on-year, due to the impact of the strong yen. The segment secured operating income of ¥307 million, but that was a decline of ¥1.656 billion year-on-year, and resulted from lower net sales and increased development expenses.

Net sales in the Finetech Business came to ¥19.964 billion, up 43.1% year-on-year, on strong growth in sales of projectors, projection aligners and chip defect inspection systems. The sharp rise in net sales resulted in operating income of ¥1.362 billion. This represented a ¥1.927 billion year-on-year improvement.